NCT04191967View on ClinicalTrials.gov

Thermocoagulation for Treatment of Precancerous Cervical Lesions

NACompletedINTERVENTIONAL
Enrollment

379

Participants

Timeline

Start Date

September 25, 2019

Primary Completion Date

November 30, 2021

Study Completion Date

November 30, 2021

Conditions
Human Immunodeficiency VirusHPV InfectionCIN 2/3
Interventions
DEVICE

Thermocoagulation

Treatment of positive screening results will be performed using the Liger Thermocoagulator device

Trial Locations (1)

Unknown

Kenya Medical Research Institute, Kisumu

All Listed Sponsors
collaborator

National Institutes of Health (NIH)

NIH

collaborator

Fogarty International Center of the National Institute of Health

NIH

lead

University of California, San Francisco

OTHER

NCT04191967 - Thermocoagulation for Treatment of Precancerous Cervical Lesions | Biotech Hunter | Biotech Hunter